Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

JHL Biotech Raises $35 Million to Fund Drug Development

publication date: Jun 19, 2014
JHL Biotech, a Taiwan-China biopharma, raised $35 million in a Series B financing. The company was founded by Genentech and Amgen veterans who want to use their knowledge of innovative process development to make biologic drugs affordable. Even though the company was started only one and one-half years ago, it already has five biosimilars and one new molecular entity in development. JHL will use the money to expand its Taiwan facility and purchase additional equipment for its commercial plant in Wuhan, China, currently under construction. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital